TX-01 30MG is a lyophilized research grade formulation that has batch verified identity and purity with CoA documentation. Manufactured in a facility that has been certified for controlled laboratory research under GMP. RUO only.
Original price was: $ 480.$ 275Current price is: $ 275.
TX-01 30MG is a proprietary research formulation supplied as a lyophilized powder for controlled laboratory and in vitro research. In addition, BioPeak USA tests each batch for identity and purity and provides a batch-specific Certificate of Analysis (CoA). Furthermore, BioPeak USA classifies this material for Research Use Only (RUO).
For laboratory research, TX-01 30MG provides a documented material format that supports analytical workflows and controlled research environments. Moreover, researchers can use the accompanying batch documentation to support laboratory records and material traceability. As a result, the available documentation helps researchers maintain organized material records.
| Specification | Details |
|---|---|
| Product Name | TX-01 30MG |
| Format | Lyophilized powder |
| Quantity | 30MG per vial |
| Purity | ≥99% |
| Testing | HPLC + Mass Spectrometry |
| Documentation | Batch-specific Certificate of Analysis |
| Research Classification | Research Use Only (RUO) |
| Analytical Methods | HPLC, ESI-MS, Karl Fischer Titration |
For quality verification, BioPeak USA uses analytical testing to document key quality attributes for each batch. In addition, researchers can review the available documentation when they evaluate materials for laboratory research. Therefore, the product information provides useful context for laboratory material selection and recordkeeping.
First, analytical characterization helps researchers examine the identity, purity, and documented properties of research materials. For example, HPLC can support chromatographic purity analysis, while mass spectrometry can help verify molecular identity.
In addition, TX-01 30MG connects with broader analytical research practices that use complementary laboratory techniques. Similarly, researchers can review scientific literature and analytical references when developing their own validated research workflows. As a result, researchers can compare documented material information with their specific laboratory requirements.
For additional scientific context, researchers can review the relevant PubMed record: PubMed scientific reference
Likewise, the National Institute of Standards and Technology (NIST) provides information about biochemical and exposure science research: NIST Biochemical and Exposure Science Group
To begin with, BioPeak USA evaluates TX-01 30MG through analytical methods that include HPLC and mass spectrometry. Next, the company records the resulting analytical information in batch-specific documentation.
As a result, researchers can review a Certificate of Analysis (CoA) for relevant batch information. In addition, the CoA supports laboratory documentation, material identification, and research recordkeeping. Therefore, researchers can use the documentation when reviewing material specifications for controlled research.
For more information about analytical documentation, visit: BioPeak USA CoA Testing
Furthermore, researchers should review the product documentation before incorporating any research material into a laboratory workflow.
In particular, TX-01 30MG comes in lyophilized powder form. As a result, this format supports standardized material handling within controlled laboratory environments.
For laboratory handling, qualified researchers should follow their established procedures and the applicable product documentation. Also, researchers should maintain appropriate records for material identification, storage, testing, and experimental use.
However, laboratory procedures can vary according to the research objective and validated protocols. Therefore, researchers should select handling practices that align with their own laboratory requirements. At the same time, laboratories should maintain appropriate documentation throughout their research workflow.
For storage, researchers should store unopened lyophilized material at −20°C according to the product documentation. In addition, researchers should maintain suitable storage conditions and follow established laboratory procedures.
Before handling the material, researchers should review the available product information and batch documentation. Moreover, laboratories should maintain appropriate records for storage conditions and material identification.
For this purpose, researchers can use the batch-specific CoA as part of their laboratory documentation and traceability process. As a result, the laboratory can maintain a clearer record of the material associated with a specific batch.
Importantly, BioPeak USA designates TX-01 30MG for Research Use Only (RUO). Therefore, researchers should use this material only within appropriate laboratory or in vitro research settings.
Specifically, researchers should not use the material for human use, animal use, clinical administration, or therapeutic applications. Likewise, this product does not represent a drug, treatment, dietary supplement, or diagnostic material.
For additional terms and conditions, review the BioPeak USA documentation: BioPeak USA Terms and Conditions
First of all, batch-level documentation gives researchers access to information associated with a specific material lot. In turn, this approach supports laboratory recordkeeping and helps researchers maintain traceability throughout their research workflow.
Furthermore, analytical information can help researchers compare material documentation with their own laboratory requirements. When researchers maintain consistent records, they can more clearly document the materials used during laboratory studies.
Consequently, batch-specific documentation can support organized research records. In addition, documented analytical information provides useful reference points for laboratory material evaluation.
Therefore, TX-01 30MG combines a defined lyophilized format with analytical testing and batch-specific documentation for research environments.
In simple terms, TX-01 30MG is a proprietary research formulation supplied as a 30MG lyophilized powder. Furthermore, BioPeak USA provides the material for Research Use Only laboratory and in vitro research.
According to the product specifications, BioPeak USA specifies ≥99% purity for TX-01 30MG. In addition, the company evaluates purity through analytical methods that include HPLC and mass spectrometry.
Yes. BioPeak USA provides a batch-specific Certificate of Analysis (CoA) with the research material. As a result, researchers can use this documentation for material verification and laboratory recordkeeping.
For analytical testing, BioPeak USA uses methods that include HPLC, ESI-MS, and Karl Fischer Titration. Together, these methods provide analytical information for research material evaluation.
For storage purposes, researchers should store unopened lyophilized material at −20°C according to the applicable product documentation. In addition, researchers should follow their established laboratory procedures.
No. BioPeak USA designates TX-01 30MG for Research Use Only. Therefore, researchers should not use the material for human, animal, clinical, diagnostic, or therapeutic applications.
Overall, TX-01 30MG provides a documented lyophilized research material for controlled laboratory and in vitro research. In addition, BioPeak USA supports each batch with analytical testing and a batch-specific Certificate of Analysis.
Furthermore, the combination of HPLC, mass spectrometry, and additional analytical methods gives researchers documented information for material evaluation and laboratory recordkeeping. By reviewing the product specifications, CoA documentation, and applicable laboratory procedures, researchers can maintain a clear and traceable research workflow.
Ultimately, TX-01 30MG offers a defined research material format supported by batch-specific documentation and analytical information for qualified laboratory research.
